{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:24:59Z","timestamp":1773174299080,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003086","name":"Basque Government","doi-asserted-by":"publisher","award":["IT989-16"],"award-info":[{"award-number":["IT989-16"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EiTB maratoia (Bioef)","award":["BIO15\/CA\/022\/BC"],"award-info":[{"award-number":["BIO15\/CA\/022\/BC"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.critrevonc.2019.04.013","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:08:08Z","timestamp":1556363288000},"page":"7-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review"],"prefix":"10.1016","volume":"139","author":[{"given":"Javier","family":"Arzuaga-Mendez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8378-1495","authenticated-orcid":false,"given":"Endika","family":"Prieto-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elixabet","family":"Lopez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idoia","family":"Martin-Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Garc\u00eda-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Africa","family":"Garc\u00eda-Orad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2019.04.013_bib0005","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.7754\/Clin.Lab.2016.160615","article-title":"Cell free DNA and Procalcitonin as early markers of complications in ICU patients with multiple trauma and major surgery","volume":"62","author":"Ahmed","year":"2016","journal-title":"Clin. Lab."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0010","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1373\/clinchem.2016.255315","article-title":"Multiplex droplet digital PCR quantification of recurrent somatic mutations in diffuse large B-Cell and follicular lymphoma","volume":"62","author":"Alcaide","year":"2016","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0020","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/annonc\/mdn374","article-title":"Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas","volume":"19","author":"Amara","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0025","first-page":"1","article-title":"Tumor-specific methylations in circulating cell-free DNA as clinically applicable markers with potential to substitute mutational analyses","author":"Andersen","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.18632\/genesandcancer.127","article-title":"The liquid biopsy in lung cancer","volume":"7","author":"Ansari","year":"2016","journal-title":"Genes Cancer"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.12439","article-title":"Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma","volume":"163","author":"Armand","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood-2016-02-699520","article-title":"Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma","volume":"128","author":"Assouline","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0045","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","volume":"28","author":"Barrans","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.suronc.2017.08.001","article-title":"Circulating cell-free DNA in plasma of colorectal cancer patients - a potential biomarker for tumor burden","volume":"26","author":"Bhangu","year":"2017","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0055","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4103\/0973-1482.157345","article-title":"Novel diagnostic biomarker for patients with Non-Hodgkin\u2019s Lymphoma by IgH gene rearrangement","volume":"12","author":"Bo","year":"2016","journal-title":"J. Cancer Res. Ther."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0060","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.3324\/haematol.2015.123612","article-title":"Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis","volume":"100","author":"Bohers","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41408-018-0111-6","article-title":"Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort","volume":"8","author":"Bohers","year":"2018","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0070","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1172\/JCI70626","article-title":"Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis","volume":"123","author":"Caganova","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0075","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3109\/10428194.2016.1139703","article-title":"Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma","volume":"57","author":"Camus","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/14737159.2017.1319765","article-title":"The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential","volume":"17","author":"Camus","year":"2017","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0085","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-18-0586","article-title":"A study of pre-analytical variables and optimization of extraction method for circulating tumor DNA measurements by digital droplet PCR","author":"Cavallone","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0090","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0095","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.gene.2018.09.029","article-title":"Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: a systemic review and meta-analysis","volume":"679","author":"Chen","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0100","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0105","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0110","first-page":"181","article-title":"Circulating nucleic acids (CNAs) and cancer--a survey","volume":"1775","author":"Fleischhacker","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0115","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/modpathol.2008.27","article-title":"Frequent hypermethylation of DBC1 in malignant lymphoproliferative neoplasms","volume":"21","author":"Gr\u00f8nbaek","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0120","first-page":"85","article-title":"Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment","volume":"1869","author":"Guo","year":"2018","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.18632\/oncotarget.235","article-title":"IgH gene rearrangements as plasma biomarkers in Non- Hodgkin\u2019s lymphoma patients","volume":"2","author":"He","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2014.222679","article-title":"Circulating tumor DNA as a liquid biopsy for cancer","volume":"61","author":"Heitzer","year":"2015","journal-title":"Clin. Chem."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/pros.23477","article-title":"Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients","volume":"78","author":"Hendriks","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0140","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/bjh.14311","article-title":"Next-generation sequencing-based detection of circulating tumour DNA after allogeneic stem cell transplantation for lymphoma","volume":"175","author":"Herrera","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0145","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/annonc\/mdp006","article-title":"Cell-free circulating DNA in Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas","volume":"20","author":"Hohaus","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0150","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1182\/blood-2012-06-435842","article-title":"MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma","volume":"121","author":"Horn","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0155","first-page":"1","article-title":"Circulating tumor DNA assessment in patients with diffuse large B-cell lymphoma following CAR T-cell therapy","author":"Hossain","year":"2018","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0160","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/bjh.13463","article-title":"Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis","volume":"170","author":"Howlett","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0165","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/annonc\/mdw531","article-title":"Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations","volume":"28","author":"Iwama","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0175","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MOH.0000000000000249","article-title":"The many layers of epigenetic dysfunction in B-cell lymphomas: Current Opinion in Hematology","volume":"23","author":"Jiang","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0185","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-017-1208-6","article-title":"Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease","volume":"15","author":"Karlas","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0190","first-page":"618","article-title":"Circulating tumor DNA as a liquid biopsy: current clinical applications and future directions","volume":"31","author":"Komatsubara","year":"2017","journal-title":"Oncology (Williston Park, N.Y.)"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0195","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.18632\/oncotarget.2394","article-title":"Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma","volume":"5","author":"Kristensen","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13148-016-0261-y","article-title":"Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma","volume":"8","author":"Kristensen","year":"2016","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0205","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2015-03-635169","article-title":"Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing","volume":"125","author":"Kurtz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0210","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.78.5246","article-title":"Circulating tumor DNA measurements As early outcome predictors in diffuse large B-Cell lymphoma","author":"Kurtz","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11864-016-0425-1","article-title":"Circulating tumor DNA to monitor therapy for aggressive B-Cell lymphomas","volume":"17","author":"Kwok","year":"2016","journal-title":"Curr. Treat. Opt. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0220","first-page":"9","article-title":"Methylation of LINE-1 in cell-free DNA serves as a liquid biopsy biomarker for human breast cancers and dog mammary tumors","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0225","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.clon.2017.03.008","article-title":"Circulating cell-free DNA utility for the surveillance of patients with treated diffuse large B-cell lymphoma","volume":"29","author":"Li","year":"2017","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00277-017-3043-5","article-title":"Assessment of the circulating cell-free DNA marker association with diagnosis and prognostic prediction in patients with lymphoma: a single-center experience","volume":"96","author":"Li","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079044","article-title":"Comparison of methods for quantification of global DNA methylation in human cells and tissues","volume":"8","author":"Lisanti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.critrevonc.2015.08.006","article-title":"TP53 dysfunction in diffuse large B-cell lymphoma","volume":"97","author":"Lu","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"731\u2013738","key":"10.1016\/j.critrevonc.2019.04.013_bib0245","first-page":"744","article-title":"Molecular monitoring of cell-free circulating tumor DNA in non-Hodgkin lymphoma","volume":"30","author":"Melani","year":"2016","journal-title":"Oncology (Williston Park, N.Y.)"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0250","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.18632\/oncotarget.14439","article-title":"LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer","volume":"8","author":"Nagai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0255","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/jcp.2009.065227","article-title":"Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment","volume":"62","author":"Obermann","year":"2009","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-018-0660-y","article-title":"Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers","author":"Panagopoulou","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0265","first-page":"15","article-title":"Emerging concepts in liquid biopsies","author":"Perakis","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0270","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s12094-015-1382-z","article-title":"Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients","volume":"18","author":"Powr\u00f3zek","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0275","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/aas.12947","article-title":"Serial perioperative cell-free DNA levels in donors and recipients undergoing living donor liver transplantation","volume":"61","author":"Prakash","year":"2017","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0280","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(15)70106-3","article-title":"Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study","volume":"16","author":"Roschewski","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0285","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0290","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-05-719641","article-title":"Diffuse large B-cell lymphoma genotyping on the liquid biopsy","author":"Rossi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0295","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8545","article-title":"Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA","volume":"8","author":"Scherer","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0300","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-Cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0305","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.14694\/EdBook_AM.2015.35.e458","article-title":"Cell-of-Origin in diffuse large B-Cell lymphoma: are the assays ready for the clinic?","author":"Scott","year":"2015","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0310","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajpath.2012.07.028","article-title":"Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype","volume":"181","author":"Sebasti\u00e1n","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0315","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.molonc.2015.12.005","article-title":"Blood circulating tumor DNA for non\u2010invasive genotyping of colon cancer patients","volume":"10","author":"Siravegna","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0320","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3693096","article-title":"Concentration and methylation of cell-free DNA from blood plasma as diagnostic markers of renal Cancer","volume":"2016","author":"Skrypkina","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0325","first-page":"11","article-title":"Circulating cell-free DNA and RNA analysis as liquid biopsy: optimal centrifugation protocol","author":"Sorber","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0330","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1749-6632.2001.tb03894.x","article-title":"Alu repeat sequences are present in increased proportions compared to a unique gene in plasma\/serum DNA: evidence for a preferential release from viable cells?","volume":"945","author":"Stroun","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0335","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0340","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.canlet.2016.02.002","article-title":"Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules","volume":"374","author":"Szpechcinski","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0345","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1183\/13993003.00676-2015","article-title":"Circulating free DNA concentration is an independent prognostic biomarker in lung cancer","volume":"46","author":"Tissot","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0350","first-page":"330","article-title":"The role and diagnostic value of cell-free DNA in systemic lupus erythematosus","volume":"35","author":"Truszewska","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.10.029","article-title":"Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients","volume":"88","author":"Valpione","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0360","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ajh.24751","article-title":"Global hypomethylation is an independent prognostic factor in diffuse large B cell lymphoma","volume":"92","author":"Wedge","year":"2017","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0365","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.clinbiochem.2018.10.002","article-title":"The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients","volume":"63","author":"Wu","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0370","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2019.04.013_bib0375","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4149\/neo_2010_06_507","article-title":"Better detection of Ig heavy chain and TCR\u03b3 gene rearrangement in plasma cell-free DNA from patients with non-Hodgkin Lymphoma","volume":"57","author":"Zhong","year":"2010","journal-title":"Neoplasma"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819300770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819300770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:28:24Z","timestamp":1760902104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842819300770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":75,"alternative-id":["S1040842819300770"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.013","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}